Is Hong Kong’s Listing Regime for Biotech Companies Viable? – Practicalities for Giving Credence to Listings under the New Chapter 18A of the Listing Rules
Biotech Listing Credance Enhancement 20180602分类：Newsletters
香港股票市场的重新定位
香港联交所发布关于首次公开招股的灵活定价机制
SEHK’s Proposal to Reform the Independent Directors Regime and Strengthen the Corporate Governance of Listed Companies
联交所对控股股东连续性要求出具新指引
SFC and HKEX Released Joint Consultation Conclusions on Listing Regulation
New Disclosure of Interests Online System (DION System)
JML就港交所创新板之咨询函的建议
香港证监会对于持牌法团的新要求
港交所实质性修改上市规则并创设新板
“债券通”对香港资本市场的影响
Risk-based ESG Reporting
Propositions of Crowdfunding Regime in Hong Kong – Part II
Propositions of Crowdfunding Regime in Hong Kong – Part I
Use of Advertisement and Guides for Prospectuses in Hong Kong